Pre-Market Review: Opko Health Inc., DaVita HealthCare Partners Inc., The Medicines Co., and Life Technologies Corp.

  Pre-Market Review: Opko Health Inc., DaVita HealthCare Partners Inc., The
                  Medicines Co., and Life Technologies Corp.

Editor Note: For more information about this release, please scroll to bottom.

PR Newswire

LONDON, November 21, 2013

LONDON, November 21, 2013 /PRNewswire/ --

On Wednesday, November 20, 2013, all three indexes of the US equity market
edged lower. The S&P 500 ended the day at 1,781.37, down 0.36%; the Dow Jones
Industrial Average closed at 15,900.82, down 0.41%; and the NASDAQ Composite
finished at 3,921.27, down 0.26%. Shares in the healthcare sector fluctuated
between gains and losses, even as the broader market declined. The major
movers in the sector included Opko Health Inc. (NYSE: OPK), DaVita HealthCare
Partners Inc. (NYSE: DVA), The Medicines Co. (NASDAQ: MDCO), and Life
Technologies Corp. (NASDAQ: LIFE). AAAResearchReports.com initiated
preliminary technical research on OPK, DVA, MDCO, and LIFE. These free reports
are accessible by signing today at:

http://www.aaaresearchreports.com/register/ 

Opko Health Inc.'s stock rallied 7.75% on Wednesday, even as the broader
market posted losses. The company's shares closed the day at$10.29 after
oscillating between$9.55 and $10.40 during the trading session. A total of
6.04 million shares were traded, which is above the daily average volume of
4.78 million. The company's shares have gained 2.39% in the last three trading
sessions and 20.21% in the previous three months, compared to a loss of 0.93%
and a gain of 7.81% in the S&P 500 during the respective periods. Furthermore,
Opko Health Inc.'s stock is trading above its 50-day and 200-day moving
averages of $9.89 and $7.94, respectively. The free technical analysis on OPK
is available by signing up at:

http://www.AAAResearchReports.com/OPK112113.pdf

On Wednesday, shares in DaVita HealthCare Partners Inc. ended the day at
$57.84, down 0.79%, after oscillating between $57.81 and $58.87 during the
trading session. A total of 1.78 million shares were traded, which is above
the daily average volume of 1.59 million. The company's shares have advanced
3.33% in the previous three months, underperforming the S&P 500, which has
gained 7.81% during the same period. However, DaVita HealthCare Partners
Inc.'s stock is trading above its 50-day moving average of $57.28. Register
now to download free research on DVA at:

http://www.AAAResearchReports.com/DVA112113.pdf

The Medicines Co.'s stock closed Wednesday's trading session at $36.73, which
is 0.78% lower than the previous day's closing price of $37.02. The company's
shares vacillated between $36.43 and $37.28 during the trading session. A
total of 0.66 million shares were traded, which is below the daily average
volume of 0.85 million. Despite Wednesday's losses, the company's shares have
surged 20.98% in the previous three months and 11.27% in the last one month,
outperforming the S&P 500, which has gained 7.81% and 2.11% during the
respective periods. Further, The Medicines Co.'s stock is trading above its
50-day and 200-day moving averages of $34.14 and $32.81, respectively. A free
report on MDCO can be accessed by registering at:

http://www.AAAResearchReports.com/MDCO112113.pdf 

Shares in Life Technologies Corp. finished Wednesday's session at$75.63, up
0.03%. The company's stock oscillated between$75.54 and$75.63 during the
trading session. A total of 1.07 million shares were traded, which is below
the daily average volume of 1.45 million. The company's shares have gained
0.19% in the previous three trading sessions, outperforming the S&P 500, which
has lost 0.93% during the same period. Moreover, Life Technologies Corp.'s
stock is trading near its 52-week high of $75.75 and also above its 50-day and
200-day moving averages of $75.12 and $71.77, respectively. Register with AAA
Research Reports and download research on LIFE for free at:

http://www.AAAResearchReports.com/LIFE112113.pdf

----

EDITOR NOTES:

1.This is not company news. We are an independent source and our views do
    not reflect the companies mentioned.
2.Information in this release is fact checked and produced on a best efforts
    basis and reviewed by Ananya Ghosh, a CFA charterholder. However, we are
    only human and are prone to make mistakes. If you notice any errors or
    omissions, please notify us below.
3.This information is submitted as a net-positive to companies mentioned, to
    increase awareness for mentioned companies to our subscriber base and the
    investing public.
4.If you wish to have your company covered in more detail by our team, or
    wish to learn more about our services, please contact us at
    pubco@EquityNewsNetwork.com.
5.For any urgent concerns or inquiries, please contact us at
    compliance@EquityNewsNetwork.com.
6.Are you a public company? Would you like to see similar coverage on your
    company? Send us a full investors' package to
    research@EquityNewsNetwork.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This
document, article or report is prepared and authored by Equity News Network.
An outsourced research services provider represented by Ananya Ghosh, CFA, has
only reviewed the information provided by Equity News Network in this article
or report according to the Procedures outlined by Equity News Network. Equity
News Network is not entitled to veto or interfere in the application of such
procedures by the outsourced provider to the articles, documents or reports,
as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or otherwise),
of the information provided in this document. This information is not to be
construed as personal financial advice. Readers are encouraged to consult
their personal financial advisor before making any decisions to buy, sell or
hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned
at the time of printing of this document or any error, mistake or shortcoming.
No liability is accepted by Equity News Network whatsoever for any direct,
indirect or consequential loss arising from the use of this document. Equity
News Network expressly disclaims any fiduciary responsibility or liability for
any consequences, financial or otherwise arising from any reliance placed on
the information in this document. Equity News Network does not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the information. The
included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA
Institute.

AAAresearchreports.com

SOURCE AAA Research Reports

Contact: +1(646)396-9126, Contact Name: Peter F. Jones, Email ID:
info@aaaresearchreports.com
 
Press spacebar to pause and continue. Press esc to stop.